Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Am Chem Soc ; 142(24): 10869-10880, 2020 06 17.
Artigo em Inglês | MEDLINE | ID: mdl-32456416

RESUMO

The ability to create ways to control drug activation at specific tissues while sparing healthy tissues remains a major challenge. The administration of exogenous target-specific triggers offers the potential for traceless release of active drugs on tumor sites from antibody-drug conjugates (ADCs) and caged prodrugs. We have developed a metal-mediated bond-cleavage reaction that uses platinum complexes [K2PtCl4 or Cisplatin (CisPt)] for drug activation. Key to the success of the reaction is a water-promoted activation process that triggers the reactivity of the platinum complexes. Under these conditions, the decaging of pentynoyl tertiary amides and N-propargyls occurs rapidly in aqueous systems. In cells, the protected analogues of cytotoxic drugs 5-fluorouracil (5-FU) and monomethyl auristatin E (MMAE) are partially activated by nontoxic amounts of platinum salts. Additionally, a noninternalizing ADC built with a pentynoyl traceless linker that features a tertiary amide protected MMAE was also decaged in the presence of platinum salts for extracellular drug release in cancer cells. Finally, CisPt-mediated prodrug activation of a propargyl derivative of 5-FU was shown in a colorectal zebrafish xenograft model that led to significant reductions in tumor size. Overall, our results reveal a new metal-based cleavable reaction that expands the application of platinum complexes beyond those in catalysis and cancer therapy.


Assuntos
Amidas/química , Antineoplásicos/farmacologia , Cisplatino/farmacologia , Morfinanos/química , Platina/química , Animais , Antineoplásicos/química , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Cisplatino/química , Liberação Controlada de Fármacos , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Estrutura Molecular , Neoplasias Experimentais/tratamento farmacológico , Neoplasias Experimentais/patologia , Peixe-Zebra
2.
J Org Chem ; 83(9): 5114-5122, 2018 05 04.
Artigo em Inglês | MEDLINE | ID: mdl-29659282

RESUMO

Molecular iron maidens are a strained type of cyclophane in which a methine hydrogen, by the action of the bridges, is placed closer to the center of an aromatic ring. Such constrained molecular frameworks are in fact a noteworthy synthetic challenge. The present study provides a comprehensible theoretical analysis that elucidates unique structural and energetic aspects of this class of molecules, evaluating, in the light of quantum chemistry, both the influence of the aromatic moiety, from π-basic to π-acid, and the nature of the heteroatoms located at the bridges. Our results not only propose the shortest intramolecular centered C-H···π distance to date, which is supported by calculated 1H chemical shifts, but also shed light on the main factors that rationalize and justify such proximity. QTAIM, NBO, and NCI analyses allow us prematurely to conclude that the ultrashort C-H···π distance is sustained by an interplay between a large stabilizing electrostatic component with a non-negligible covalent character. However, the energetics involving such strained molecular scaffolds, addressed by means of isodesmic reactions, revealed that the C-H···π proximity is modulated mainly by the capacity of the bridges to support the strain imposed by the whole structure, hence compressing the C-H bond against the π-system.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA